Racial disparities in opioid prescription and pain management among breast cancer survivors

被引:4
作者
Kim, Sunny Jung [1 ,2 ]
Retnam, Reuben P. P. [3 ]
Sutton, Arnethea L. L. [1 ]
Edmonds, Megan C. C. [4 ]
Bandyopadhyay, Dipankar [2 ,5 ]
Sheppard, Vanessa B. B. [1 ,2 ]
机构
[1] Virginia Commonwealth Univ, Sch Med, Dept Hlth Behav & Policy, 830 East Main St,4th Floor, Richmond, VA 23298 USA
[2] Virginia Commonwealth Univ, Massey Canc Ctr, Richmond, VA 23298 USA
[3] Takeda Pharmaceut, Virginia, MA USA
[4] Icahn Sch Med Mt Sinai, Div Gen Internal Med, New York, NY USA
[5] Virginia Commonwealth Univ, Sch Med, Dept Biostat, Richmond, VA 23298 USA
来源
CANCER MEDICINE | 2023年 / 12卷 / 09期
关键词
cancer patients; opioids; pain management disparity; ADJUVANT ENDOCRINE THERAPY; QUALITY-OF-LIFE; HORMONAL-THERAPY; ADULT; PREVALENCE; SOCIETY; WOMEN; RACE;
D O I
10.1002/cam4.5755
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: We examined whether there are racial disparities in pain management, opioid medicine prescriptions, symptom severity, and quality of life constructs in breast cancer survivors.Methods: We conducted a secondary analysis of longitudinal data from the Women's Hormonal Therapy Initiation and Persistence (WHIP) study (n = 595), a longitudinal study of hormonal receptor-positive breast cancer survivors. Upon study enrollment, patients completed a survey assessing an array of psychological, behavioral, and treatment outcomes, including adjuvant endocrine therapy (AET)-induced symptoms, and provided a saliva biospecimen. Opioid prescription records were extracted from the health maintenance organizations (HMOs) pharmacy database. The final analytic sample included women with complete HMO pharmacy records for 1 year.Results: There were 251 eligible patients, of which 169 (67.3%) were White. The average age was 61.09 years old (SD = 11.07). One hundred seventy-two patients (68.5%) had received at least one opioid medication and 37.1% were prescribed opioids longer than 90 days (n = 93). Sixty-four Black patients (78%) had a record of being prescribed with opioids compared to 64% of White patients (n = 108, p = 0.03). Black patients reported worse vasomotor, neuropsychological, and gastrointestinal symptoms, as well as lower quality of life and greater healthcare discrimination than White patients (p's < 0.05). Black patients were more likely to be prescribed opioids for 90 days or longer compared to White patients, when controlling for age, marital status, income, body mass index (BMI), cancer stage, and chemotherapy status (adjusted Odds Ratio = 2.72, p = 0.014).Conclusion: Findings indicate that there are racial differences in opioid prescriptions supplied for pain management and symptomatic outcomes. Future research is needed to understand the causes of disparities in cancer pain management and symptomatic outcomes.
引用
收藏
页码:10851 / 10864
页数:14
相关论文
共 53 条
[1]   Developing and Implementing a Web-Based Psychotherapy Program to Address Mental Health Challenges Among Patients Receiving Oncologic and Palliative Care: Protocol for an Open-Label Randomized Controlled Trial [J].
Alavi, Nazanin ;
Stephenson, Callum ;
Miller, Shade ;
Khalafi, Payam ;
Sinan, Israa ;
Kain, Danielle ;
McDougall, Maggie ;
Davies, Julia ;
Stark, Debora ;
Tompkins, Erin ;
Jagayat, Jasleen ;
Omrani, Mohsen ;
Shirazi, Amirhossein ;
Groll, Dianne ;
Soares, Claudio .
JMIR RESEARCH PROTOCOLS, 2021, 10 (07)
[2]  
Allison P.D., 2008, CONVERGENCE FAILURES
[3]  
[Anonymous], 2018, WHO guidelines for the pharmacological and radiotherapeutic management of cancer pain in adults and adolescents
[4]   Addressing the Rural Opioid Addiction and Overdose Crisis Through Cross-Sector Collaboration: Little Falls, Minnesota [J].
Au-Yeung, Caroline ;
Blewett, Lynn A. ;
Lange, Kathy .
AMERICAN JOURNAL OF PUBLIC HEALTH, 2019, 109 (02) :260-262
[5]  
Bird Sheryl Thorburn, 2001, Ethnicity and Disease, V11, P554
[6]   Reliability and validity of the functional assessment of cancer therapy-breast quality-of-life instrument [J].
Brady, MJ ;
Cella, DF ;
Mo, F ;
Bonomi, AE ;
Tulsky, DS ;
Lloyd, SR ;
Deasy, S ;
Cobleigh, M ;
Shiomoto, G .
JOURNAL OF CLINICAL ONCOLOGY, 1997, 15 (03) :974-986
[7]   Chronic Pain in Breast Cancer Survivors: Comparison of Psychosocial, Surgical, and Medical Characteristics Between Survivors With and Without Pain [J].
Bredal, Inger Schou ;
Smeby, Nina A. ;
Ottesen, Stig ;
Warncke, Torhild ;
Schlichting, Ellen .
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 2014, 48 (05) :852-862
[8]   Chronic opioid therapy in long-term cancer survivors [J].
Carmona-Bayonas, A. ;
Jimenez-Fonseca, P. ;
Castanon, E. ;
Ramchandani-Vaswani, A. ;
Sanchez-Bayona, R. ;
Custodio, A. ;
Calvo-Temprano, D. ;
Virizuela, J. A. .
CLINICAL & TRANSLATIONAL ONCOLOGY, 2017, 19 (02) :236-250
[9]   Racial differences in opioid use for chronic nonmalignant pain [J].
Chen, I ;
Kurz, J ;
Pasanen, M ;
Faselis, C ;
Panda, M ;
Staton, LJ ;
O'Rorke, J ;
Menon, M ;
Genao, I ;
Wood, J ;
Mechaber, AJ ;
Rosenberg, E ;
Carey, T ;
Calleson, D ;
Cykert, S .
JOURNAL OF GENERAL INTERNAL MEDICINE, 2005, 20 (07) :593-598
[10]   Chronic Opioid Use and Central Sleep Apnea: A Review of the Prevalence, Mechanisms, and Perioperative Considerations [J].
Correa, Denis ;
Farney, Robert J. ;
Chung, Frances ;
Prasad, Arun ;
Lam, David ;
Wong, Jean .
ANESTHESIA AND ANALGESIA, 2015, 120 (06) :1273-1285